Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (455)	12/7/1999 10:38:00 AM
From: Larry Liebman	Respond to of 1475

FWIW...I added some shares at $6 this morning. With a market cap of $53 million, I'm willing to play the game at this level, with such news.

To: scaram(o)uche who wrote (455)	12/7/1999 5:25:00 PM
From: LLCF	Read Replies (1) \| Respond to of 1475

<The lack of a requirement for permanent chimerism for long-term acceptance of an organ graft in a recipient of a bone marrow and kidney graft from the same donor has been clinically demonstrated. > Are they saying that as long as one receives both kidney AND bone marrow from the same donor at the same time there is no rejection? No immuno suppressive drugs needed? Wonder what % of kidney transplants are candidates for this proceedure? DAK